Adamis Pharmaceuticals Corp 4
4 · Adamis Pharmaceuticals Corp · Filed Jul 24, 2013
Insider Transaction Report
Form 4
Rahman Ahmed Shayan Fazlur
10% Owner
Transactions
- Sale
Common Stock, par value $0.0001
2013-07-22$0.60/sh−20,000$12,012→ 29,955,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.60/sh−5,000$3,000→ 29,950,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.59/sh−24,900$14,691→ 29,833,843 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.56/sh−10,000$5,601→ 29,940,067 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.56/sh−66,000$36,960→ 29,863,743 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-23$0.58/sh−5,000$2,900→ 29,858,743 total(indirect: See Footnote) - Sale
Common Stock, par value $0.0001
2013-07-22$0.56/sh−10,324$5,781→ 29,929,743 total(indirect: See Footnote)
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.